MTRI · InMed Pharmaceuticals Inc. · Investor Relations
$18.79
+0.44 (+2.37%)
At close · Nov 13
Return incl. dividend (before tax)
Q4 2021 earnings call transcript
Going-concern doubt
— flagged Nov 3, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued.”View the 10-Q filed Nov 3, 2026
Market Cap
$8.58M
Shares
549,374
Volume · Nov 13
7698
Avg daily vol (6 sessions)
62.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2025-12-11 | Life Sciences Virtual Investor Forum | Event |
| 2025-09-18 | InMed Presenting at Life Sciences Investor Forum | Event |
| 2024-11-12 | Fierce Biotech Webinar: Alzheimer’s Outlook – Neuroinflammation, the Next Step | Event |
| 2024-08-01 | Alzheimer’s Association International Conference® | Conference |
| 2024-06-20 | Benzinga Healthcare + Biotech Breakthroughs | Event |
| 2024-06-13 | Emerging Growth Conference | Conference |
| 2024-02-01 | The Microcap Conference 2024 | Conference |
| 2024-01-25 | Water Tower Research Fireside Chat with InMed CEO Eric A. Adams | Event |
| 2023-12-01 | MJ Biz Con | Event |
| 2023-11-07 | 12th World Congress on Itch (WCI) 2023 | Event |
| 2023-06-01 | Investor Summit | Event |
| 2023-05-31 | Tribe Public Webinar | Event |
| 2023-05-23 | Fireside Chat with Water Tower Research | Event |